The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

Escalating every six weeks instead of four: what I observed over eight months — one year on

KH
ka.haddadTL219 Dec 2024#1

On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion.

Asking about Escalating every six weeks instead directly, because I have read four threads on it and each answered a slightly different question.

The version I want answered is the narrow one: given the method stated below, is the result within what anyone else has seen? I am not asking what it means yet.

Method, numbers and the two assumptions I am aware of making are below. If the assumptions are wrong that is more useful to me than agreement.

2 likes 19mo
MP
mira.patelTL4 Admin30 Dec 2024#2

Helpful, and short, which on this subject is harder than long.

6 likes 19mo
LS
l.solbergTL28 Jan 2025#3

Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense.

16 likes 19mo
EV
e.verhoevenTL215 Jan 2025 · edited#4
mira.patel, post #2: Helpful, and short, which on this subject is harder than long. Go to post

Answering the question the opening post raises rather than the one it answers.

Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.

31 likes in reply to #2 18mo
LP
l.piresTL222 Jan 2025#5
ka.haddad, post #1: On the subject in the title: Escalating every six weeks instead of four: what I observed over eight months — one year on Working notes rather than a conclusion. Asking about Escalating every six weeks instead directly, because I have read four threads on it and each answered a slightly different question. The version I want answered is… Go to post

Two questions I would want answered before drawing anything from the Escalating every six weeks instead data above: how were the cases selected, and what happened to the ones that dropped out.

0 likes in reply to #1 18mo
HM
h.mensahTL228 Jan 2025#6

On Escalating every six weeks instead the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.

3 likes 18mo
LO
l.oseiTL24 Feb 2025#7
AA
a.asanteTL210 Feb 2025#8

Post #4 describes the usual case. This is about the unusual one.

Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind most disappointment.

One more caveat and then I will stop qualifying: the sample selected itself.

23 likes 18mo
MV
m.vukovicTL215 Feb 2025#9

Fine by me. I had wanted a stronger conclusion and there is not one available.

0 likes 17mo
MD
m.dalgaardTL3Regular21 Feb 2025#10

Worth separating two things that post #8 runs together.

The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat it as one.

1 like 17mo
DH
dietitian_hollisTL3Dietitian27 Feb 2025#11
m.vukovic, post #9: Fine by me. I had wanted a stronger conclusion and there is not one available. Go to post

The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you are assessing a stable concentration rather than a rising one.

Second-hand, so weight it accordingly.

0 likes in reply to #9 17mo
HA
h.agyemanTL24 Mar 2025#12
l.osei, post #7: Adding the measurement that post #6 says would settle it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. Go to post

Taking post #11 at face value and following it one step further.

Two things can be true about Escalating every six weeks instead at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people defending the first against attacks on the second.

21 likes in reply to #7 17mo
JW
journalclub_wrenTL3Regular9 Mar 2025#13

I read post #11 twice before replying, because I had assumed the opposite.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

5 likes 17mo
EH
e.halonenTL214 Mar 2025#14

Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a good one.

0 likes 16mo
PW
PharmNotes_WhitfieldTL4Pharmacist20 Mar 2025#15
dietitian_hollis, post #11: The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you are assessing a stable concentration rather than a rising one. Second-hand, so weight it accordingly. Go to post

If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.

That is my reading. Someone else read the same page differently and was reasonable.

0 likes in reply to #11 16mo
SC
s.cabreraTL225 Mar 2025#16

A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day of each week.

I would want a second opinion before relying on that.

28 likes 16mo
NA
n.abernathyTL3Analytical chemist29 Mar 2025 · edited#17

Good question, well framed, and I would like to see it answered properly.

9 likes 16mo
SM
s.mbekiTL23 Apr 2025#18

Narrowing post #15, because the general version has more than one answer.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

2 likes 16mo
OF
outline_firstTL3Wiki editor8 Apr 2025#19

On post #15 — agreed on the reasoning, with one qualification.

On Escalating every six weeks instead: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here including this one.

21 likes 16mo
CC
c.castellanosTL213 Apr 2025#20
s.cabrera, post #16: A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day of each week. I would want a second opinion before relying on that. Go to post

Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.

9 likes in reply to #16 15mo
SO
s.okaforTL218 Apr 2025#21
PharmNotes_Whitfield, post #15: If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure. That is my reading. Someone else read the same page differently and was reasonable. Go to post

The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.

27 likes in reply to #15 15mo
LG
lc_gradientTL3Analytical chemist22 Apr 2025 · edited#22

Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose. Escalating before steady state means escalating on incomplete information about the dose you are on.

0 likes 15mo
RE
r.erdoganTL227 Apr 2025#23

Building on post #20 rather than restating it.

The practical version of Escalating every six weeks instead is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.

2 likes 15mo
DB
dr_bhattacharyaTL3Physician1 May 2025#24

Post #22 put the caveat in the right place and I want to underline it.

I would keep Escalating every six weeks instead and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.

9 likes 15mo
KP
k.perrinTL26 May 2025#25
c.castellanos, post #20: Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle. Go to post

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

20 likes in reply to #20 15mo
BN
bench_notesTL4 Moderator10 May 2025#26

Escalating every six weeks instead looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

0 likes 15mo
AV
a.vukovicTL215 May 2025#27

Taking post #24 at face value and following it one step further.

If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure.

The literature is thinner on this than the confidence in the thread implies.

0 likes 14mo
RA
r.aldana_pharmdTL4Pharmacist19 May 2025 · edited#28
e.halonen, post #14: Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a good one. Go to post

Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind most disappointment.

5 likes in reply to #14 14mo
RV
r.villalobosTL224 May 2025#29
RD
r.danquahTL228 May 2025#30

I read post #26 twice before replying, because I had assumed the opposite.

An update on my earlier Escalating every six weeks instead post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.

2 likes 14mo